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Humanized bone marrow-liver-thymic (hu-BLT) mice develop a functional immune system
in periphery, nevertheless, have a limited reconstitution of human myeloid cells, especially
microglia, in CNS. Further, whether bone marrow derived hematopoietic stem and
progenitor cells (HSPCs) can enter the brain and differentiate into microglia in adults
remains controversial. To close these gaps, in this study we unambiguously demonstrated
that human microglia in CNS were extensively reconstituted in adult NOG mice with
human interleukin-34 transgene (hIL34 Tg) from circulating CD34+ HSPCs, nonetheless
not in hu-BLT NOGmice, providing strong evidence that human CD34+ HSPCs can enter
adult brain and differentiate into microglia in CNS in the presence of hIL34. Further, the
human microglia in the CNS of hu-BLT-hIL34 NOG mice robustly supported HIV-1 infection
reenforcing the notion that microglia are the most important target cells of HIV-1 in CNS and
demonstrating its great potential as an in vivo model for studying HIV-1 pathogenesis and
evaluating curative therapeutics in both periphery and CNS compartments.
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INTRODUCTION
Microglia, the resident macrophages in the central nervous system (CNS), are the key resident
immune cells to maintain neuronal homeostasis, defend against infections, and are associated with
the pathogenesis of many neurodegenerative diseases (1–3). The ontology of adult brain microglia
has been debated for a long time. The consensual view to date is that microglia in CNS is the seeding
results of primitive hematomyeloid precursor cells from yolk sac and aorta-gonad-mesonephros
region in early embryo life and proliferation in situ thereafter (4–8). However, multiple studies
also showed that bone marrow derived cells can enter the brain and differentiate into microglia
in adults (9–11).
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Humanized mice (hu-mice) with a human immune system
have been extensively used in investigating the ontology of
immune cells, immunopathogenesis of human specific
pathogens, and evaluating therapeutics as preclinical small
animal models (12–15). Hu-mice generated by engrafting
human CD34+ hematopoietic stem and progenitor cells
(HSPCs) in neonatal life can reconstitute macrophages in the
meninges and perivascular spaces, but rarely in the parenchyma
of brain (16, 17). Similarly, humanized bone marrow-liver-
thymic (hu-BLT) mice engrafted with human fetal liver and
thymic tissues and HSPCs at adults develop a functional immune
system in periphery but have a limited reconstitution of human
myeloid cells, especially microglia, in CNS (18). We previously
demonstrated that human interleukin-34 transgenic (hIL34-Tg)
NOG mice engrafted intrahepatically with CD34+ HSPCs at
birth significantly reconstituted microglial-like cells in the CNS
(19). However, it remained unknown whether adult hIL34-Tg
NOGmice could also reconstitute human microglia in CNS until
this study. The hu-BLT mice are the best hu-mice in terms of
human immune reconstitution, as they are engrafted with
human fetal thymic tissues in addition to human liver tissues
and liver derived CD34+ HSPCs where human T cells can receive
differentiation and selection education in human thymic tissues
(20, 21). This study has been poised to address two questions
using the hu-BLT hIL34-Tg NOG (hu-BLT-hIL34) mouse
model. First, we wanted to investigate whether human
parenchymal microglia in the CNS could be reconstituted in
adult hIL34 Tg mice from circulating myeloid precursor cells
derived from CD34+ HSPCs. This is a fundamental question
regarding the origin of human microglia in CNS at adults. The
second question was to test the susceptibility of the reconstituted
human microglia to HIV-1 infection.
Using this unique system and by comparing two types of hu-
BLT mice with and without hIL34 Tg received the same human
donor tissues, we unambiguously demonstrated that human
microglia in CNS can be extensively reconstituted in adult
hIL34 Tg NOG mice but no in NOG mice, which provides
strong evidence that human CD34+ HSPCs can enter adult brain
and differentiate into microglia in the CNS in the presence of
hIL34. Further, the human microglia in the CNS of hu-BLT-
hIL34 mice are susceptible to HIV-1 infection, which reenforced
the notion that microglia are the most important target cells of
HIV-1 in CNS and demonstrated its great potential as an in vivo
model for studying HIV-1 pathogenesis and evaluating curative
therapeutics in both periphery and CNS compartments.
METHOD
Ethics
All methods associated with animals described in this study were
conducted in accordance with the Institutional Animal Care and
Research Committee (IACUC) approved protocols at the
University of Nebraska-Lincoln (UNL) and University of
Nebraska Medical Center (UNMC).
hIL34-Tg NOG and NOG Mice
NOG (NOD.Cg-Prkdcscid Il2rgtm1Sug/JicTac) mice of 6-8-week-
old were purchased from Taconic Biosciences (Rensselaer, NY
12144, United States) and housed at the UNL Life Sciences
Annex under specific-pathogen-free conditions. The hIL34-Tg
NOGmice were bred at UNMC by pairing hIL34-Tg mouse with
NOG mouse of opposite gender. The offspring were genotyped
after three weeks of age by obtaining DNA from the tail snipping.
Genotyping was performed for hIL34 as described previously
using real-time polymerase chain reaction (19). Mice positive for
hIL34 were transferred to UNL to generate hu-BLT mice.
Generation of hu-BLT-hIL34 and
hu-BLT Mice
To investigate human microglia reconstitution in the CNS of hu-
BLT-hIL34 mice, both hu-BLT-hIL34 and hu-BLT mice were
generated from adult hIL34-Tg NOG and NOG mice as we
previously reported (22, 23) (Figure 1A). Briefly, 6-to-8-week-old
adult hIL34-Tg NOG mice and NOG mice received sublethal
irradiation at the dose of 12 cGy/gram of body weight with an
RS2000 X-ray irradiator (Rad Source Technologies). Mice were
surgically engrafted with a sandwich of two pieces of human fetal
liver and one piece of thymic tissue fragments under the murine left
renal capsules, of which human fetal livers and thymus tissues were
procured from the Advanced Bioscience Resources. Within 6 hours
after surgery, a total of 2.3 × 105 fetal liver derived CD34+ HSPCs
in 200 ul volume was injected through tail vein. At 16 weeks post
engraftment, the immune reconstitution in the peripheral blood was
assessed using flow cytometry as described below.
Human Brain Tissues
To compare the human microglia from hu-BLT-hIL34 mice with
humans, ethically sourced human autopsy cerebral cortex tissues
from a deidentified individual of HIV-1 negative with no
registered medical complications were obtained from the NIH
Neuro BioBank (https://neurobiobank.nih.gov/).
Multicolor Flow Cytometry
Multicolor flow cytometry was conducted as previously reported
(22, 23) for assessing the human immune reconstitution of
peripheral blood mononuclear cells (PBMCs) at 16- and 20-
weeks post transplantation (Figure 1B). Briefly, peripheral blood
was collected from a great saphenous vein into the
ethylenediaminetetraacetic acid (EDTA)-containing vial (BD
Microtainer, Franklin Lakes, NJ, USA). Red blood cells were
lysed using fluorescence activated cell sorting (FACS) lysing
solution (BD Biosciences, USA). The PBMCs were resuspended
in a FACS buffer (2% FBS in phosphate-buffered saline) and
incubated with a cocktail of following monoclonal antibodies
against human immune cell markers at 4°C for 30 min: anti-
hCD45-fluorescein isothiocyanate (FITC), anti-hCD3-
Phycoerythrin (PE), anti-hCD19-Phycoerythrin-Cyanin 5 (PE-
Cy5), anti-hCD4-Alexa Fluor 700 (AF700), anti-hCD8-
allophycocyanin-Cyanin 7(APC-Cy7) and anti-hCD14-Brilliant
Violet 605 (BV605). All above antibodies and isotype control
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antibodies were obtained from BD Biosciences, USA. The stained
cells were washed with FACS buffer and fixed with 4%
paraformaldehyde. Raw data were acquired by FACSAria III
(BD Biosciences) and analyzed with FlowJo version 7.6.4
(TreeStar). Statistical analysis was performed using GraphPad
Prism 7 (GraphPad Software). Two groups of female hu-BLT-
hIL34 (n=6) and hu-BLT mice (n=10) with good human immune
cell reconstitutions in the peripheral blood (Table 1) were selected
for this study.
HIV-1 Infection and Measurement of
HIV-1 Plasma Viral Loads
To investigate the infectivity of HIV-1 in parenchymal human
microglial cells in the CNS, 4 mice (# 1703, 1705, 1708 and 1709)
of the hu-BLT-hIL34 mice group and 5 mice (# 1720, 1723, 1724,
1726, and 1728) in the hu-BLT mice group were randomly
selected (Table 1) and intraperitoneally inoculated with the 105
tissue culture infectious dose 50 (TCID50) of macrophage-tropic
HIV-1 ADA in 200ml volume (obtained through the NIH AIDS
Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 ADA
Virus from Dr. Howard Gendelman). At 2- and 4-weeks post
HIV-1 inoculation, HIV-1 plasma viral load (pVL) in copies/ml
was determined by real-time RT-PCR using our previously
published protocol (24). Briefly, viral RNA was extracted from
the plasma using QIAamp ViralRNA minikit (Qiagen) as
recommended by the manufacturer and quantified using
C1000 ThermalCycler and the CFX96 Real-Time system (Bio-




FIGURE 1 | Experimental timeline and Flow Cytometric evaluation of human immune cells reconstitutions in the peripheral blood of hu-BLT-hIL34 and hu-BLT mice.
(A) Experimental design and timeline for the humanization of hIL34 transgenic mice and NOG mice by engrafting with human CD34+ hematopoietic stem and
progenitor cells (HCSPs) and human fetal liver and thymic tissues, HIV-1 Ada infection of some mice in each group, and the evaluation of human myeloid and
microglial cell reconstitution and HIV-1 infection in the CNS of euthanized mice using immunohistochemical staining (IHCS) and RNAscope in situ hybridization (ISH).
(B) The representative flow cytometric dot plots of the peripheral blood mononuclear cells of a hu-BLT-hIL34 mouse (#1703) at the 4 months after transplantation,
which were gated with hCD45+, hCD3+, hCD9+, and hCD14+ cells. (C) The percentage of hCD14+ myeloid cells in the peripheral blood of hu-BLT-hIL34 mice is
significantly higher than that hu-BLT mice at the 4 months post transplantation. Each symbol represents an individual mouse, hu-BLT-hIL34 mice n=6, hu-BLT mice
n=10; ****p < 0.0001.
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Fast Virus 1-Step master mix (Life Technologies) and following
primers and probe combination (IDT, USA) were used: Forward
Primer, GCCTCAATAAAGCTTGCCTTGA; Reverse Primer,
G GGCGCCACTGCTAGAGA ; P r o b e , / 5 6 - F AM /
CCAGAGTCA/ZEN/CACAACAGACGGGCACA/3IABkFQ/.
Euthanasia of All the Mice for Evaluating
Human Myeloid Cell Reconstitution and
HIV-1 Infection in the CNS
After two consecutive positive results of HIV-1 pVL at 2- and 4-
weeks post HIV-1 inoculation, which is equivalent to the 21- to
23-weeks post transplantation, all the mice, including HIV-1
infected and non-inoculated subgroups from the hu-BLT-hIL34
and hu-BLT mice groups, were euthanized for analyzing human
myeloid cell reconstitutions and HIV-1 infections in the CNS
(Figure 1A). Whole brain was dissected out during necropsy and
sliced coronally into 5 parts at 4 mm interval using a young mouse
brain slicer (Cat# BSMYS001-1, Zivic Instruments, Pittsburgh, PA,
USA). The brain tissues and other tissues including spinal cord,
spleen, lymph node, jejunum and ileum were collected and fixed in
SafeFix™ II (Cat# 042600, Fisher Scientific, USA) at room
temperature for 6 hours and embedded in paraffin.
Immunohistochemical Staining (IHCS)
To evaluate the phenotype, morphology and distribution of the
reconstituted humanmyeloid cells in the CNS, IHCS was conducted
by following our previously published protocol with slight
modifications (25). Briefly, antigen retrieval of 6-mm thick tissue
sections were performed in 0.1mM citrate buffer (PH 6.0) by
heating at 98°C for 15 mins. The following primary antibodies
were used for detecting macrophage/microglial cells: rabbit
monoclonal-antibody (mAb) to human ionized calcium-binding
adaptor molecule 1 (hIba-1, EPR6136-2 clone, Cat# ab221933,
1:500; Abcam, USA), rabbit polyclonal antibody to human
TMEM119-C-terminal (hTMEM119, Cat# ab185333, 1:500;
Abcam, USA), rabbit mAb to human CD14 (hCD14, EPR3653
clone, Cat. # 133335, 1:1000; Abcam, USA), mouse mAb to human
CD68 (hCD68, PG-M1 clone, Cat# MS-1808-S1, 1:100;
Thermoscientific, USA), mouse mAb to human CD163 (hCD163,
10D6 clone, Cat# NCL-L-CD163, 1:100; Leica Biosystems, USA).
For HIV-1 detection, mouse mAb to HIV-1 gag p24 (Kal-1 clone,
Cat# M0857, 1:10, Dako, USA) was used. Mouse or rabbit IgG
isotype control antibodies were used as negative control. Dako
EnVision+ system-HRP labelled polymer anti-rabbit kit (Code
K4002, Dako, USA) or anti-mouse kit (Code K4000, Dako, USA),
and the Betazoid DAB Chromogen Kit (Cat# BDB2004, BioCare
Medical, USA) were used for signal detection and visualization. The
cell nuclei were counterstained with Mayer’s hematoxylin. The
stained tissue sections after completion of IHCS were digitized
with Aperio CS2 Scanscope and the quantitative image analysis of
positive cells was conducted using a positive pixel count algorithm
in Aperio’s Spectrum Plus analysis program (version 9.1; Aperio
ePathology Solutions) as previously reported (26).
HIV-1 Viral RNA Detection Using
RNAscope In Situ Hybridization (ISH)
HIV-1 viral RNA (vRNA) in the brain tissues were detected
using RNAscope ISH according to our previously published
protocol (26). Briefly, HIV-1 antisense probes of RNAscope®
ISH probe-V-HIV1-clade B (Cat# 416111) and RNAscope® 2.5
HD assay-Red kit were used. The RNAscope® probe-DapB (Cat#
310043) was used as a negative control. All the reagents above
were purchased from the Advanced Cell Diagnostics, Inc.
Combined RNAscope ISH With IHCS
To determine the cell types of HIV-1 vRNA+ cells in the CNS, a
combined RNAscope ISH and IHCS method was used as reported
(26). Briefly, after the completion of RNAscope ISH for HIV-1
vRNA and digitization of the whole tissue section, the slides were
soaked in xylene overnight to remove the coverslip and the tissue
TABLE 1 | The blood human immune cells reconstitutions of hu-BLT-hIL34 and hu-BLT mice.
Group Mouse ID hCD45 (%) hCD3+ (%) hCD8+ (%) hCD4+ (%) hCD19+ (%) hCD14+ (%)
Hu-BLT-hIL34 1699 92.10 88.90 14.70 83.80 7.76 1.98
1703 91.30 90.50 15.90 82.60 4.54 2.49
1705 16.60 94.60 49.00 49.00 0.88 2.05
1707 85.80 99.60 10.80 88.40 0.02 1.13
1708 83.50 91.20 11.80 87.00 4.93 2.16
1709 7.62 87.80 55.00 41.00 5.79 2.15
Mean 62.82 92.10 26.20 71.97 3.99 1.99
SD 39.52 4.35 20.16 21.14 2.97 0.46
Hu-BLT 1717 83.80 22.40 47.70 49.50 67.80 1.16
1718 89.50 84.30 19.80 78.50 13.20 0.37
1720 42.90 94.70 20.80 78.20 3.14 0.44
1721 78.90 99.50 11.20 87.90 0.02 0.13
1722 56.30 23.90 46.60 51.40 69.70 0.70
1723 89.10 64.20 24.30 73.60 32.70 0.55
1724 70.30 97.60 15.50 83.80 1.24 0.86
1726 64.70 54.70 72.10 26.50 31.00 1.01
1728 94.30 81.40 18.20 80.10 15.50 0.39
1729 93.30 83.60 17.30 80.90 13.10 0.55
Mean 76.31 70.63 29.35 69.04 24.74 0.62
SD 17.32 28.71 19.56 19.81 25.74 0.32
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section was rehydrated and subjected to IHCS using the rabbit mAb
to hIba-1 (clone# EPR6136-2, Cat# ab221933, 1:500; Abcam, USA)
as the primary antibody as described in the IHCS section above.
Rabbit IgG isotype control antibody was used as negative control.
RESULTS
Human Myeloid Cell Reconstitution
in the CNS
CNS contains four types of macrophages: parenchymal microglia
and nonparenchymal perivascular macrophages (PVM), meningeal
macrophages (MM) as well as choroid plexus macrophages (2, 8).
First, we used antibodies to hIba-1, hCD14, hCD68 and hCD163,
sensitive markers of macrophages and microglial cells (27–30), to
evaluate human myeloid cells reconstitutions in the CNS of hu-
BLT-hIL34 and hu-BLT mice. We examined human myeloid cells
and microglial reconstitutions in the CNS of all six hu-BLT-hIL34
mice using IHCS with antibodies to hIBA-1, hCD14, hCD68,
hCD163, and hTMEM119. To compare, we also evaluated the
human myeloid cells and microglial reconstitution in 6 hu-BLT
mice using IHCS with above antibodies. The frequency and
distribution of human myeloid cells and microglial cells in CNS
of these mice are highly consistent among these different antibodies.
There were extensively reconstitutions of human myeloid cells
in the CNS parenchyma of hu-BLT-hIL34 mice as indicated by
hIba-1+ cells (Figure 2 and Supplementary Figure 1), hCD14+
cells (Figure 3 and Supplementary Figure 2), CD68+ cells
FIGURE 2 | The hIba-1+ myeloid cell reconstitutions in the brain tissues of hu-BLT-hIL-34 and hu-BLT mice. The upper panel (A–E) shows a representative whole
brain tissue section from the third coronal brain slice of a hu-BLT-hIL34 mouse (#1703) that was stained immunohistochemically for hIba-1+ (brown) and
counterstained with hematoxylin. LV stands for lateral ventricle. The blue and red boxed regions in the Figure C were highlighted at a higher magnification (A, D).
In turn, the blue and red boxed regions of the (A, B) were further highlighted (B, E). The hIba-1+ cells are morphologically ramified and mainly distributed in brain
parenchyma. The lower panel (F–J) shows a representative whole brain tissue section (H) of a hu-BLT mouse (#1717) that was stained immunohistochemically for
hIba-1+ cells (brown). The blue and red boxed regions in the Figure H was highlighted at a higher magnification (F, I). In turn, the blue and red boxed regions of the
(F, I) were further highlighted (G, J). There were no detectable parenchymal hIba-1+ cells.
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(Supplementary Figure 2) and CD163+ cells (Supplementary
Figure 3) using IHCS. As shown in a representative whole brain
tissue section from the third coronary slice (Figure 2C) of all hu-
BLT-hIL34 mouse (#1703), hIba-1+ cells in the brain parenchyma
were extensively reconstituted across multiple regions of the brain.
The Figures 2A, D respectively highlighted the cerebral cortex and
hippocampus boxed regions from the Figure 2C; in turn, Figures
2B, E respectively further highlighted the boxed regions from the
Figures 2A, D at a higher magnification.We also detected extensive
reconstitution of hIba-1+ cells in spinal cord (Supplementary
Figures 1A, B, mouse# 1708) and cerebellum tissues
(Supplementary Figures 1C, D, mouse#1708) of hu-BLT-hIL34
mice. The hIba-1+ cells are numerous, morphologically ramified,
distributed in brain parenchyma. Consistent with the extensive
reconstitution of parenchymal human myeloid cells in the CNS
revealed by hIba-1+ cells, there were also abundant hCD14+
myeloid cells as shown in a representative whole brain tissue
sections (Figures 3A–C, mouse#1708) of hu-BLT-hIL34 mice.
The blue and red boxed regions of cerebral cortex and
hippocampus in the Figure 3B were respectively highlighted at a
higher magnification in the Figures 3A, C. The hCD14+ cells are
again morphologically ramified and mainly distributed in brain
parenchyma. Consistent with the extensive reconstitutions of hIBa-
1+ and hCD14+ cells above mentioned, there were also abundant
hCD68+ cells (Supplementary Figure 2) and hCD163+ cells
(Supplementary Figure 3) in the brain of hu-BLT-hIL34 mice.
We thus concluded that hu-BLT-hIL34 mice extensively
reconstituted parenchymal human myeloid cells in the CNS,
including cerebral cortex, hippocampus, thalamus hypothalamus,
striatum, amygdala, spinal cord, and cerebellum (Figures 2, 3 and
Supplementary Figures 1–3). In contrast and as expected, there
were an absence of detection or very limited reconstituted hIBa-1+
cells (Figures 2F–J, Supplementary Figures 1E–H), hCD14+ cells
(Figures 3D–F and Supplementary Figure 2), hCD68+ cells
(Supplementary Figure 2), or hCD163+ cells (Supplementary
Figures 3D–F) cells in the CNS of the hu-BLT mice. As shown
in a representative whole brain tissue section from the third coronal
slice (Figures 2F–J, mouse#1717) of hu-BLT mice, hIba-1+ cells
were absent in all the parenchyma of cerebral brain (Figures 2F–J).
Similarly, hCD14+ cells were also absent in the parenchyma of hu-
BLT mice (Figures 3D–F, mouse#1723). We next compare the
reconstitution of nonparenchymal perivascular macrophages and
meningeal macrophages in the hu-BLT-hIL34 and hu-BLTmice. As
indicated by hIba-1, hCD14, hCD163 expression and their
anatomic distribution, hu-BLT-hIL34 mice also have a better
reconstitution of meningeal macrophages (MM) and perivascular
macrophages (PVM) than hu-BLT mice (Figures 2, 3 and
Supplementary Figures 1–3).
The Myeloid Cells in Brain Parenchyma
Expressed Microglia-Specific Marker
hTMEM119
To distinguish parenchymal microglia from macrophages, we
conducted IHCS using microglial-specific marker hTMEM119
FIGURE 3 | The hCD14+ myeloid cell reconstitutions in the brain tissues of hu-BLT-hIL34 BLT and hu-BLT mice. The upper panel (A–C) shows representative
whole brain tissue sections and the highlighted images form the corresponding boxed regions from hu-BLT-hIL34 mouse (#1708) that were stained
immunohistochemically for hCD14+ cells (brown) and counterstained with hematoxylin. There were abundant hCD14+ cells (A–C) in the brain of the hu-BLT-hIL34
mouse. The lower panel (D–F) in contrast shows no detectable hCD14+ myeloid cells in the brain parenchyma and a very limited number of hCD14+ cells in
meninges in a representative whole brain tissue section of a hu-BLT mouse (#1723).
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(31, 32). There were extensively reconstitutions of hTMEM119+
cells in theCNSparenchymaofhu-BLT-hIL34mice (Figures4A–F,
mouse#1703). As shown in a representative whole brain tissue
section from the third coronal slice (Figure 4C), hTMEM119+ cells
in the brain parenchyma were extensively reconstituted across
multiple regions of the brain. The Figures 4A, D respectively
highlighted the boxed regions of the cerebral cortex and
hippocampus from the Figure 4C; in turn Figures 4B, E
respectively further highlighted the boxed regions from the
Figures 4A, D at a higher magnification. The hTMEM119+ cells
are morphologically ramified and distributed in parenchyma. We
quantified hTMEM119 + cells in the cerebral cortex of the hu-BTL-
hIL34 mice (n=6) and found there were 304.08 ± 131.93 (mean ±
SD) hTMEM119+ microglial cells/mm2, whereas there were an
absent of these cells in the hu-BLT mice. We further compared
hTMEM119 + cells in the cerebral cortex of anHIV-1 non-infected
individual, who had no registered medical complications at NIH
Neuro Biobank. We found that the frequency, morphology, and
FIGURE 4 | The microglia-specific marker hTMEM119+ microglia in the brain tissues of hu-BLT-hIL34 and hu-BLT mice and humans. A representative whole brain tissue
section (C) from the third coronal brain slice of a hu-BLT-hIL34 mouse (#1703) that was stained immunohistochemically for hTMEM119+ cells (brown) and counterstained with
hematoxylin. LV stands for lateral ventricle. The blue and red boxed regions in the Figure (C) were highlighted at a higher magnification (A, D). In turn, the blue and red boxed
regions of the Figures (A, D) were highlighted (B, E). The hTMEME119+ cells (brown) are morphologically ramified and distributed in brain parenchyma. The histogram of
quantitative images analysis of hTMEM119 + cells in the cerebral cortex of the hu-BTL-hIL34 mice (F) (304.08 ± 131.93 hTEME119+ cells/mm2, n=6), where there were an
absent of these cells in the hu-BLT mice. The middle panel (G–I) shows hTMEM119 + microglia in the cerebral cortex of a HIV-1 non-infected individual with no registered
medical complications (G–I). The frequency, distribution, and morphology of hTMEM119+ human microglia in hu-BLT-hIL34 mice are similar to this human individual. The
lower panel (J–L) shows no detectable hTMEM119+ cells in a representative whole brain section of a hu-BLT mouse (#1721).
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distributionofhTMEM119+cells inhu-BLT-hIL34miceare similar
to that person (Figures 4G–I). In contrast, there were an absence of
detectable hTMEM119+ cells in the CNS of the hu-BLT mice
(Figures 4J–L, mouse#1721). We thus concluded that hu-BLT-
hIL34 mice extensively reconstituted human microglia in the CNS.
HIV-1 Infection in the CNS
of hu-BLT-hIL34 Mice
To test the functionality of reconstituted human myeloid cells in
the CNS of hu-BLT-hIL34 mice, we infected 4 animals from hu-
BLT-hIL34 group and 5 animals from hu-BLT mice groups
(Supplemental Table 1). At 4-6 weeks post HIV-1 infection, we
euthanized all 4 hu-BLT-hIL34 mice that were inoculated with
HIV-1 Ada. We detected abundant HIV-1 vRNA+ and p24+ cells
in the brain tissues of all 4 hu-BLT-hIL34 mice that were
inoculated with HIV-1 (Figures 5A–D, mouse#1708) but there
were undetectable HIV-1 vRNA+ cells in three hu-BLT mice that
were inoculated with HIV-1 and examined (Figures 5E, F,
mouse#1724). As shown in representative images in the Figure 5,
there were abundantHIV-1 RNA+ cells (red) in the brain tissues of
hu-BLT-hIL34 mouse (#1708) detected using RNAscope ISH with
HIV-1 clade B probe. Consistentwith the results ofHIV-1VRNA+
cells, there were abundant HIV-1 p24+ cells detected using IHCS.
We further defined theHIV-1 vRNA+ cells type as humanmyeloid
cells using IHCS with hIba-1 marker (Figure 5D, arrows)
indicating the reconstituted human myeloid cells can support
HIV-1 infection. In contrast, we did not detect any HIV-1 vRNA
+ cells in the brain of hu-BLT mice (Figures 5E, F, mouse#1724).
FIGURE 5 | The HIV-1 infection of human microglia of hu-BLT-hIL34 mice. The Upper panel shows HIV-1 RNA+ cells (A, B, red) in a representative whole brain
tissue section from a hu-BLT-hIL34 mouse (#1708) that was detected using RNAscope in situ hybridization with HIV-1 clade B anti-sense probe and counterstained
with hematoxylin. The highlighted boxed region from the Figure (A) was shown at a higher magnification of HIV-1 RNA+ cells (B, red). HIV-1 p24+ cells (C, brown) in
the cerebral cortex of the same mouse were detected using IHCS. The colocalization of HIV-1 vRNA and human myeloid cell marker hIba-1 (D, arrows) indicating the
reconstituted human myeloid cells could support HIV-1 replication. The lower panel (E, F) shows there were no detectable HIV-1 RNA+ cells in a representative
whole brain tissue section from a hu-BLT mouse (#1724) using RNAscope in situ hybridization.
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DISCUSSION
In this study, we demonstrated that human microglia can be
extensively reconstituted in CNS from circulating human HSPCs
in hu-BLT-hIL34 mice. We first used a battery of human myeloid
cell markers, including hIBa-1, hCD14, hCD68 and hCD163, to
evaluate human myeloid cell reconstitution in the CNS and
found that human myeloid cells were extensively reconstituted
and primarily localized in the brain parenchyma (Figures 2, 3
and Supplementary Figures 1–3). We then used a human
microglial specific marker, hTMEM119, to validate these
reconstituted human myeloid cells in the brain parenchyma
are mainly human microglia (Figures 4A–F). Further, in
comparison with hTMEM119 + microglia in the cerebral
cortex of a HIV-1 non-infected individual with no registered
medical complications (Figures 4G–I), we found the frequency,
distribution, and morphology of hTMEM119+ human microglia
in hu-BLT-hIL34 mice are similar to this person. Our data thus
support the notion that human microglia at adults can be
generated through human hematopoietic stem and progenitor
cells (HSPC), which is consistent with the previous reports that
bone marrow derived cells can enter brain to different into
microglia at adults (9–11). In contrast, we did not observe
human microglia reconstitution in the brain parenchymal of
hu-BLT mice (Figures 2–4 and Supplementary Figures 1–3
lower panels). The hu-BLT-hIL34 and hu-BLT mice are
genetically identical and also received the same human donor
transplant except the former had hIL34 knock-in, indicating that
hIL34, a ligand of the colony stimulating factor-1 receptor, play
an important role in myeloid and microglial cells development in
CNS (19, 33). This study is unique in the following aspects. First
human myeloid and microglia cells reconstitution in the CNS is a
clear-cut result in this chimeric mouse and human model.
Second, the adult mice engrafted with HSPCs extensively
reconstituted human microglia in the CNS, to our knowledge
this is the first report in this regard. In addition to comparing the
parenchymal human microglia between hu-BLT-hIL34 and hu-
BLT mice, we also observed that hu-BLT-hIL34 mice had a much
better reconstitution of meningeal and perivascular macrophages
than hu-BLT mice (Figures 2, 3 and Supplementary Figure 3).
We also would like to point that both hu-BLT-hIL34 and hu-BLT
mice received sublethal irradiation, whether this irradiation
facilitated HSPCs to gain an entry into the brain and whether
without irradiation can also reconstitute the human brain
microglia in adult hIL34-NOG mice remains to be investigated.
Despite the importance of microglial cells, as a resident
macrophage, in host immune response to brain infections and
in the pathogenesis of neurodegenerative diseases, very limited
small animal models are available to recapitulate diseases
pathogenesis associated with human microglia. To that end, we
infected hu-BLT-hIL34 mice and found that reconstituted
human microglia are susceptible to HIV-1 infection in the
CNS. Moreover, HIV-1 vRNA were localized in human
myeloid cells in the brain, reenforcing that microglia cells are
the most important subtract of HIV-1 infection in the CNS (26,
34). Using hu-BLT-hIL34 mice, it is now feasible to investigate
the interplay between human pathogens, such as HIV-1, with
human immune system of periphery and CNS compartments.
The hu-BLT-hIL34 mouse model reported here open a new
avenue for investigating the pathogenesis of HIV-1 infection and
purging HIV-1 latent reservoir in the CNS in addition to
peripheral tissues.
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Supplementary Figure 1 | The hIba-1+ myeloid cell reconstitutions in the spinal
cord and cerebellum tissues of hu-BLT-hIL-34 and hu-BLT mice. The upper panel
shows abundant hIba-1+ cells (brown) from representative spinal cord (A, B,
mouse# 1708) and cerebellum (C, D, mouse# 1703) tissue sections of a hu-BLT-
hIL34 mice detected using IHCS. The lower panel shows no detectable hIba-1+
cells (brown) from representative spinal cord (E, F, mouse# 1721) and cerebellum
(G, H, mouse#1717) tissue sections of a hu-BLT mice detected using IHCS.
Supplementary Figure 2 | The comparison of human myeloid cell
reconstitutions in the cortex, corpus striatum, hippocampus, and cerebellum
tissues of hu-BLT-hIL-34 and hu-BLT mice. Every upper panel respectively shows
human myeloid lineage cells of hIba-1+, hCD14+, hCD68+ or hTMEM119+ were
extensively reconstituted throughout the cortex, corpus striatum, hippocampus and
cerebellum of brains of hu-BLT-hIL34 mice; while every lower panel respectively
shows an absence of or limited detection of these cells from hu-BLT mice using
IHCS. Each amplified micrograph was shown from the red frame in the left upper
corner thumbnails pictures. Scale bar equals 25mm.
Supplementary Figure 3 | The comparison of human meningeal macrophages
(MM) and perivascular macrophages (PVM) reconstitutions in the brain tissues of
hu-BLT-hIL-34 and hu-BLT mice. The upper panel shows abundant hCD163+
(brown) human parenchymal myeloid cells (A–C), human meningeal macrophages
(A, arrows) and human perivascular macrophages (C) from representative brain
tissue sections of a hu-BLT-hIL34 mice (#1708) detected using IHCS. The lower
panel shows an absence of hCd163+ human parenchymal myeloid cells and a few
of human meningeal macrophages (D–F, arrows) of hu-BLT mice (mouse#1726).
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